ATE289823T1 - Erhöhung der migration oder proliferation von keratinocyten - Google Patents

Erhöhung der migration oder proliferation von keratinocyten

Info

Publication number
ATE289823T1
ATE289823T1 AT97310407T AT97310407T ATE289823T1 AT E289823 T1 ATE289823 T1 AT E289823T1 AT 97310407 T AT97310407 T AT 97310407T AT 97310407 T AT97310407 T AT 97310407T AT E289823 T1 ATE289823 T1 AT E289823T1
Authority
AT
Austria
Prior art keywords
collagenase
keratinocytes
proliferation
migration
increase
Prior art date
Application number
AT97310407T
Other languages
English (en)
Inventor
Ira M Dr Herman
Original Assignee
Tufts College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tufts College filed Critical Tufts College
Application granted granted Critical
Publication of ATE289823T1 publication Critical patent/ATE289823T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0629—Keratinocytes; Whole skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT97310407T 1996-12-31 1997-12-22 Erhöhung der migration oder proliferation von keratinocyten ATE289823T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/777,267 US5718897A (en) 1995-06-07 1996-12-31 Enhancing keratinocyte migration and proliferation

Publications (1)

Publication Number Publication Date
ATE289823T1 true ATE289823T1 (de) 2005-03-15

Family

ID=25109770

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97310407T ATE289823T1 (de) 1996-12-31 1997-12-22 Erhöhung der migration oder proliferation von keratinocyten

Country Status (7)

Country Link
US (1) US5718897A (de)
EP (1) EP0852144B1 (de)
JP (1) JPH10212244A (de)
AT (1) ATE289823T1 (de)
AU (1) AU733240B2 (de)
CA (1) CA2225898C (de)
DE (1) DE69732616T2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5718897A (en) * 1995-06-07 1998-02-17 Trustees Of Tufts College Enhancing keratinocyte migration and proliferation
JP4074043B2 (ja) * 2000-03-27 2008-04-09 株式会社資生堂 皮膚基底膜形成促進剤、人工皮膚形成促進剤及び人工皮膚の製造方法
US7176243B2 (en) 2000-06-02 2007-02-13 The General Hospital Corporation CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis
US7262174B2 (en) * 2001-05-09 2007-08-28 Geron Corporation Treatment for wounds
ITPD20050207A1 (it) 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
CA2711133A1 (en) * 2008-01-08 2009-07-16 Tufts University Wound healing peptides and methods of use thereof
CA2743999A1 (en) 2008-10-27 2010-06-03 Trustees Of Tufts College Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds, and uses thereof
WO2011003236A1 (zh) 2009-07-08 2011-01-13 乔志亚生技股份有限公司 一种龙眼核萃取物的制备方法与应用
KR20120117995A (ko) 2009-12-08 2012-10-25 헬쓰포인트, 엘티디. 강화된 효소 활성을 갖는 효소적 창상 괴사조직제거 조성물
JP5946508B2 (ja) * 2014-10-31 2016-07-06 喬本生医股▲ふん▼有限公司 リュウガン種子抽出物の製造方法及びその応用
WO2016094675A1 (en) 2014-12-12 2016-06-16 Smith & Nephew, Inc. Use of clostridium histolyticum protease mixture in promoting wound healing
WO2025114817A1 (en) 2023-11-30 2025-06-05 Osiris Therapeutics, Inc. Methods and compositions for enzymatic wound debridement
WO2025181654A1 (en) 2024-02-26 2025-09-04 Smith & Nephew, Inc. Methods for measurement of endotoxin contaminants in enzymatic compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0625894A1 (de) * 1991-10-09 1994-11-30 LecTec Corporation Wässriges gel enthaltender wundverband sowie verpackung
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
EP0637450A3 (de) * 1993-08-04 1995-04-05 Collagen Corp Verfahren und Zusammensetzung zur Wiederbelebung von Nerbgewebe.
WO1996028543A1 (de) * 1995-03-16 1996-09-19 Knoll Aktiengesellschaft Neue, definierte enzymmischungen zur zellgewinnung und für die wundbehandlung
US5718897A (en) * 1995-06-07 1998-02-17 Trustees Of Tufts College Enhancing keratinocyte migration and proliferation

Also Published As

Publication number Publication date
AU4836497A (en) 1998-07-02
AU733240B2 (en) 2001-05-10
DE69732616D1 (de) 2005-04-07
EP0852144B1 (de) 2005-03-02
EP0852144A2 (de) 1998-07-08
US5718897A (en) 1998-02-17
EP0852144A3 (de) 1999-05-26
DE69732616T2 (de) 2006-04-13
JPH10212244A (ja) 1998-08-11
CA2225898A1 (en) 1998-06-30
CA2225898C (en) 2012-02-07

Similar Documents

Publication Publication Date Title
DE69732616D1 (de) Erhöhung der Migration oder Proliferation von Keratinocyten
DE69034018D1 (de) Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts
DE69622154D1 (de) Verwendung von angiogenese-suppressoren zur hemmung des haarwuchses
DE69929810D1 (de) Verwendung von tetracyclinderivaten zur steigerung der interleukin-10 produktion
NO303261B1 (no) Apparat for plantekultivering
FI940932A0 (fi) Koostumuksia ja menetelmiä haavojen hoitamiseksi
ATE65405T1 (de) Kollagen-implantat und verfahren zu seiner herstellung.
DE69634900D1 (de) Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
NO971568L (no) Analoger av keratinocyttvekstfaktor
ATE172634T1 (de) Hemmen von haarwuchs
MX7531E (es) Proceso biotecnologico para alterar la proliferacion y/o el desarrollo de cultivos tisulares
ES2062048T3 (es) Composicion cosmetica.
DE69429336D1 (de) Zusammensetzung von Pflanzenwachstums-Beschleuniger
ATE145556T1 (de) Verwendung von interleukin-4 zur behandlung der festen tumoren
DE59305464D1 (de) Verwendung von kokosvorlauffettsäure zur insektenabwehr
DE69007964D1 (de) Verwendung von Thrombospondin zur Beschleunigung der Wundheilung.
DE69406302D1 (de) Verwendung von östriolmessungen zur uberwachung tokolytischer therapie
EP0751217A3 (de) Erhöhung der Keratinocytemigration mit Clostridiopeptidase-A-Collagenase
DE69535081D1 (de) Verwendung von Prostaglandin A oder dessen Derivaten zur Behandlung von Psoriasis
ATE218862T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
DE69621447D1 (de) Verwendung von nitroflavonoide zur behandlung von angstzuständen
DE69231916D1 (de) Makroskopisch orientiertes zelladhäsionsprotein zur wundbehandlung
DE69600212D1 (de) Verwendung von Monocarbonsäuren zur Pflege von Keratinsubstanzen
ATE101045T1 (de) Verwendung von zink-calciumhydroxid, lecithin und pao zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen.
ATE216885T1 (de) Verwendung von penciclovir zur behandlung von postherpetischer neuralgie

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties